Problem statement: Answer the MCQ question.
Query: Which drug exhibits a 10.551\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
[a] O=C(CCn1c(=O)oc2ccccc21)NCc1ccc2c(c1)OCO2
[b] Cc1nn(Cc2ccccc2)c(Cl)c1/C=C1\NC(=S)NC1=O
[c] N#CCCn1cc(C(=O)Nc2ccccc2Br)c(-c2cccs2)n1
Answer: b. Cc1nn(Cc2ccccc2)c(Cl)c1/C=C1\NC(=S)NC1=O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1nn(Cc2ccccc2)c(Cl)c1/C=C1\NC(=S)NC1=O
Cc1nn(Cc2ccccc2)c(Cl)c1/C=C1\NC(=S)NC1=O
(5Z)-5-[(1-benzyl-5-chloro-3-methylpyrazol-4-yl)methylidene]-2-sulfanylideneimidazolidin-4-one